- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- homo-tetramer
- Ligands
- 8 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- FUL: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-FUL.2: 7 residues within 4Å:- Chain A: K.62, N.65, D.66, W.356, I.388
- Chain B: N.382, F.385
2 PLIP interactions:1 interactions with chain A, 1 interactions with chain B- Hydrogen bonds: A:N.65, B:N.382
NAG-NAG-BMA-FUL.14: 7 residues within 4Å:- Chain C: K.62, N.65, D.66, W.356, I.388
- Chain D: N.382, F.385
3 PLIP interactions:1 interactions with chain D, 2 interactions with chain C- Hydrogen bonds: D:N.382, C:N.65, C:D.66
- 4 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-D-mannopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN.3: 9 residues within 4Å:- Chain A: D.116, N.119
- Chain B: V.315, D.318, Y.372, G.373, T.374, G.375, S.376
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:V.315, B:G.375
- Water bridges: B:V.315, B:V.315
NAG-NAG-BMA-MAN-MAN-MAN.7: 9 residues within 4Å:- Chain B: D.116, N.119
- Chain C: V.315, D.318, Y.372, G.373, T.374, G.375, S.376
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:V.315, C:G.375
- Water bridges: C:V.315, C:V.315
NAG-NAG-BMA-MAN-MAN-MAN.15: 9 residues within 4Å:- Chain C: D.116, N.119
- Chain D: V.315, D.318, Y.372, G.373, T.374, G.375, S.376
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:V.315, D:G.375
- Water bridges: D:V.315, D:V.315
NAG-NAG-BMA-MAN-MAN-MAN.19: 9 residues within 4Å:- Chain A: V.315, D.318, Y.372, G.373, T.374, G.375, S.376
- Chain D: D.116, N.119
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:V.315, A:G.375
- Water bridges: A:V.315, A:V.315
- 2 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-FUC.6: 7 residues within 4Å:- Chain B: K.62, N.65, D.66, W.356, I.388
- Chain C: N.382, F.385
3 PLIP interactions:2 interactions with chain B, 1 interactions with chain C- Hydrogen bonds: B:N.65, B:D.66, C:N.382
NAG-NAG-BMA-FUC.18: 7 residues within 4Å:- Chain A: N.382, F.385
- Chain D: K.62, N.65, D.66, W.356, I.388
2 PLIP interactions:1 interactions with chain A, 1 interactions with chain D- Hydrogen bonds: A:N.382, D:N.65
- 4 x CA: CALCIUM ION(Non-covalent)
CA.9: 6 residues within 4Å:- Chain A: D.212, N.213, G.216, D.243, G.264, Q.266
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:D.212, A:G.216, A:G.264, A:Q.266
CA.11: 6 residues within 4Å:- Chain B: D.212, N.213, G.216, D.243, G.264, Q.266
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:D.212, B:G.216, B:G.264, B:Q.266
CA.21: 6 residues within 4Å:- Chain C: D.212, N.213, G.216, D.243, G.264, Q.266
4 PLIP interactions:4 interactions with chain C- Metal complexes: C:D.212, C:G.216, C:G.264, C:Q.266
CA.23: 6 residues within 4Å:- Chain D: D.212, N.213, G.216, D.243, G.264, Q.266
4 PLIP interactions:4 interactions with chain D- Metal complexes: D:D.212, D:G.216, D:G.264, D:Q.266
- 4 x ST5: 4-(ACETYLAMINO)-3-[(HYDROXYACETYL)AMINO]BENZOIC ACID(Non-covalent)
ST5.10: 13 residues within 4Å:- Chain A: R.37, D.70, R.71, I.141, R.143, E.146, A.165, H.193, E.195, R.211, N.213, R.290, Y.325
14 PLIP interactions:14 interactions with chain A- Hydrophobic interactions: A:R.71, A:I.141, A:Y.325
- Hydrogen bonds: A:R.71, A:R.143, A:E.195, A:R.211, A:Y.325
- Water bridges: A:R.211, A:N.213, A:R.290
- Salt bridges: A:R.37, A:R.211, A:R.290
ST5.12: 13 residues within 4Å:- Chain B: R.37, D.70, R.71, I.141, R.143, E.146, A.165, H.193, E.195, R.211, N.213, R.290, Y.325
13 PLIP interactions:13 interactions with chain B- Hydrophobic interactions: B:R.71, B:I.141, B:Y.325
- Hydrogen bonds: B:R.71, B:R.143, B:R.211, B:Y.325
- Water bridges: B:R.211, B:N.213, B:R.290
- Salt bridges: B:R.37, B:R.211, B:R.290
ST5.22: 13 residues within 4Å:- Chain C: R.37, D.70, R.71, I.141, R.143, E.146, A.165, H.193, E.195, R.211, N.213, R.290, Y.325
14 PLIP interactions:14 interactions with chain C- Hydrophobic interactions: C:R.71, C:I.141, C:Y.325
- Hydrogen bonds: C:D.70, C:R.71, C:R.143, C:R.211, C:Y.325
- Water bridges: C:R.211, C:N.213, C:R.290
- Salt bridges: C:R.37, C:R.211, C:R.290
ST5.24: 13 residues within 4Å:- Chain D: R.37, D.70, R.71, I.141, R.143, E.146, A.165, H.193, E.195, R.211, N.213, R.290, Y.325
15 PLIP interactions:15 interactions with chain D- Hydrophobic interactions: D:R.71, D:I.141, D:Y.325
- Hydrogen bonds: D:D.70, D:R.71, D:R.143, D:E.195, D:R.211, D:Y.325
- Water bridges: D:R.211, D:N.213, D:R.290
- Salt bridges: D:R.37, D:R.211, D:R.290
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Singh, S. et al., Structure-based inhibitors of influenza virus sialidase. A benzoic acid lead with novel interaction. J.Med.Chem. (1995)
- Release Date
- 1996-08-17
- Peptides
- INFLUENZA A SUBTYPE N2 NEURAMINIDASE: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- homo-tetramer
- Ligands
- 8 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- FUL: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-D-mannopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x CA: CALCIUM ION(Non-covalent)
- 4 x ST5: 4-(ACETYLAMINO)-3-[(HYDROXYACETYL)AMINO]BENZOIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Singh, S. et al., Structure-based inhibitors of influenza virus sialidase. A benzoic acid lead with novel interaction. J.Med.Chem. (1995)
- Release Date
- 1996-08-17
- Peptides
- INFLUENZA A SUBTYPE N2 NEURAMINIDASE: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B